Young researcher Millicent Dockerill becomes a BRIDGE programme fellow
The Research and Grants Office (RGO) and the Vice-Rector for Research warmly congratulate:
- Millicent Dockerill, Department of Organic Chemistry, Faculty of science, and co-founder of Reverso Therapeutics.
Further information: Reverso Therapeutics
